Alan Jiang
128 Xiangshan Northern Road
Nanchang, 330008, China
Nanchang, 330008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC.
Journal: Cell death & disease
Published: November 25, 2024
SS18-SSX drives TYK2 expression to activate STAT3/Bcl2 axis, facilitating apoptosis evasion and advancing synovial sarcoma progression.
Journal: Cell biology and toxicology
Published: June 12, 2024
GTPase GPN3 facilitates cell proliferation and migration in non-small cell lung cancer by impeding clathrin-mediated endocytosis of EGFR.
Journal: Cell death discovery
Published: June 07, 2024
PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway.
Journal: Experimental eye research
Published: May 09, 2024
VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN.
Journal: Cell death & disease
Published: April 21, 2024
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.
Journal: Investigative ophthalmology & visual science
Published: March 17, 2022
Corneal endothelial expansion using human umbilical cord mesenchymal stem cell-derived conditioned medium.
Journal: Journal of cellular physiology
Published: February 11, 2020
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma.
Journal: Experimental eye research
Published: December 10, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026